Email

mwchen@um.edu.mo

Tel

(853) 8822-4675

Office

N22-6012

Consultation Hours

Tue: 10:00-11:00
Wed: 10:00-11:00

Meiwan CHEN 陳美婉

Professor

Academic Qualifications

  • PhD      Sun Yat-sen University
  • MSc      Jinan University

Teaching

HSCI3011Pharmaceutics LabB.Sc. Course
CMED719Systems BiologyM.Sc. Course
CMED718Pharmaceutical ScienceM.Sc. Course
CMED812Pharmaceutical Engineering and Biomaterials SciencePhD Course

  • Molecular Pharmaceutics
  • Biomaterial and Nanomedicine
  • Targeted Drug Delivery System

Prof. Meiwan Chen’s research focuses on biomaterial and nanomedicine, especially on development of novel drug delivery systems for active ingredients of Chinese medicine. The research ranges from design and synthesis of novel lipidic and polymeric carriers to mechanistic understanding of delivery barriers and to in vivo studies of relevant tumor models and rheumatoid arthritis. The emphasis is on improving the efficacy of chemotherapeutics that have poor water-solubility, fast metabolism, non-selectivity, and drug resistance. Leveraging on the expertise and resources of the SKL of Quality Research in Chinese Medicine at the University of Macau, the lab also develops nanomedicines combining Chinese and Western medicinal compounds for synergistic effects.

Prof. Chen has published 240 SCI papers, and serves as the first/corresponding author of 140 papers (43 papers with IF>10) published in renowed journals such as Science Advances, Advanced Materials, and ACS Nano. Her publications have been cited >18200 times, with an h-index of 75, with 5 being recognized internationally as “ESI highly cited papers”. The highest citation for single paper has reached 685 times. She has been in charge 20 projects funded by NSFC as well as the Macau Fund. She also published 6 book chapters and 12 patents. She was awarded the Excellent Young Scientist Fund by National Natural Science Foundation of China in 2019 (the first time opened for HK and Macao applicants) and ‘Qi Huang’ Youth Scholarship by the State Administration of TCM, China in 2020. She was elected as a Fellow of the Royal Society of Chemistry (FRSC) in 2022. She won the Natural Science Award (2nd/2nd/3rd/2nd Class) in 2012/2014/2018/2024 and the Science and Technology Progress Award (3rd Class) in 2022, as awarded by the Macao Science and Technology Award.

She serves as the deputy editor-in-chief of Exploration and BME Horizon, an editorial board member of Journal of Controlled Release, Chinese Chemical Letters, Acta Pharmaceutica Sinica B, etc. She (co-)supervises more than 40 PhD/MSc graduates: one student received the National Overseas High-level Youth Talent Program, one student awarded the second prizes in the ‘Challenge Cup’ national inter-varsity competition for extracurricular academic technological projects in 2022; one graduate ranked first under Young Elite Scientist Sponsorship Programme; one student received the 9th China Youth Science and Technology Innovation Award; eight students received the Macao Science and Technology Award-Scientific and Technological R&D Awards for Postgraduates; and more than thirty conference awards.

We are looking for Ph.D. students (12500MOP/Month), master students (8000 MOP/Month), research assistants (~12000 MOP/Month), and postdoctoral fellows (~25000 MOP/Month) who are interested in Pharmaceutical Science, Biomaterials and Nanomedicine. For further information, please contact Dr. Chen at: mwchen@um.edu.mo.

陳美婉，博士，教授，博士生導師。首届國家自然科學基金優秀青年科學基金（港澳）獲得者。青年岐黃學者。英國皇家化學會會士。主要致力于生物材料與納米醫學的研究，集中在中藥活性成分的藥物遞送系統。通過設計和合成智能化可降解生物材料，構建新型脂質體和聚合物膠束等多功能納米藥物，解決藥物水溶性差、代謝快、選擇性差和易耐藥性等問題，同時還發展納米技術在中西藥聯合治療中的應用，以期實現更有效的癌症和類風濕關節炎的治療。

至今共發表SCI論文240篇，其中第一或通訊作者論文140篇（IF>10.0論文43篇），成果發表于Science Advances、Advanced Materials和ACS Nano等藥劑學和生物材料領域的國際權威期刊。5篇論文入圍“ESI高被引論文”。所有論文引用>18200次，單篇最高引用685次，H因子75。主持國家自然科學基金優秀青年科學基金項目、澳門科學技術發展基金和澳門大學基金等20項研究項目。參與6部中英文學術著作的編寫和12項中國發明專利的申請（9項授權）。榮獲第一/二/四/六/七屆澳門特別行政區自然科學獎/科技進步獎（2012/2014/2018/2022/2024）。

擔任Exploration和BME Horizon期刊副主編，Journal of Controlled Release、Chinese Chemical Letters、Acta Pharmaceutica Sinica B等期刊編委，世界中聯中藥藥劑委員會第三屆理事會常務理事兼副秘書長、中國生物材料學會生物醫用高分子材料分會委員和中國醫藥生物技術協會納米生物技術分會委員等。指導博碩士40余名：1名學生入選“國家海外高層次青年人才”；榮獲1項第17屆“挑戰杯”全國大學生課外學術科技作品競賽二等獎，1項第四屆中國科協青年人才托舉工程，1項第九屆中國青少年科技創新獎，8項澳門研究生科研獎和30余項海內外會議獎勵等。

歡迎對藥學、生物材料和納米醫學感興趣的博士研究生（月津貼12,500澳門元）、碩士研究生（月津貼8,000 澳門元）、研究助理（月薪12,000 澳門元）和博士後研究員（月薪25,000 澳門元）加入我們課題組，詳情請聯繫陳博士：mwchen@um.edu.mo。

  • 2024.11 – Macao Science and Technology Awards (2nd Prize, Natural Science Award, awarded to MW Chen), Macao
  • 2023.09 – Outstanding Editor Award, Exploration International Symposium on Biology, Chemistry, and Medicine, China
  • 2022.05 – Fellow of the Royal Society of Chemistry (FRSC), UK
  • 2020.12 – ‘Qi Huang’ Youth Scholarship, the State Administration of TCM, China
  • 2019.10 – Excellent Young Scientist Fund, NSFC, China
  • 2022.11 – Macao Science and Technology Awards (3rd Prize, Science and Technology Progress Award, awarded to I Che, MW Chen, ZQ Lin, KW Choi), Macao
  • 2018.10 – Macao Science and Technology Awards (3rd Prize, Natural Science Award, awarded to YT Wang, MW Chen, CM Wang, RB Wang), Macao
  • 2014.10 – Macao Science and Technology Awards (2nd Prize, Natural Science Award, awarded to CH Leung, YT Wang, JJ Lu, MW Chen, XP Chen), Macao
  • 2012.10 – Macao Science and Technology Awards (2nd Prize, Natural Science Award, awarded to YT Wang, SMY Lee, XP Chen, MW Chen, JJ Lu), Macao
  • 2020.05 – ICMS Academic Award 2019/2020, University of Macau, Macao
  • 2018.05 – ICMS Academic Award 2017/2018, University of Macau, Macao
  • 2017.05 – The Incentive Award Scheme for Outstanding Academic Staff 2016/2017, University of Macau, Macao

Student Awards (澳門研究生科研獎)

  • Scientific and Technological R&D Awards for Postgraduates, Macao Science and Technology Award 2024: Ruifeng Liang
  • Scientific and Technological R&D Awards for Postgraduates, Macao Science and Technology Award 2018: Yingqi Xu
  • Scientific and Technological R&D Awards for Postgraduates, Macao Science and Technology Award 2018: Yu Yang
  • Scientific and Technological R&D Awards for Postgraduates, Macao Science and Technology Award 2016: Lu Wang
  • Scientific and Technological R&D Awards for Postgraduates, Macao Science and Technology Award 2016: Yuee Cai
  • Scientific and Technological R&D Awards for Postgraduates, Macao Science and Technology Award 2014: Shengpeng Wang
  • Scientific and Technological R&D Awards for Postgraduates, Macao Science and Technology Award 2014: Ruie Chen
  • Scientific and Technological R&D Awards for Postgraduates, Macao Science and Technology Award 2012: Shengpeng Wang

Ph.D. and Master Students, Research Assistants, and Post-doctoral Fellows

Selected Former Ph.D. and Master Students’ First Job after Graduation

  • Suleixin YANG (Chengdu University of Traditional Chinese Medicine, Special Associate Professor)
  • Ruie CHEN (Guangzhou Xinhua University, Lecturer)
  • Guangjie SONG (Shenzhen University, Post-doctoral Fellow)
  • Zhaopei GUO (Changchun Institute of Applied Chemistry, Research Associate)
  • Tingting PAN (Southern University of Science and Technology, Post-doctoral Fellow)
  • Jie HU (Wenzhou Medical University, Post-doctoral Fellow)
  • Yu YANG (University of Macau, Post-doctoral Fellow)
  • Jinming ZHANG (Chengdu University of Traditional Chinese Medicine, Associate Professor)
  • Shengpeng WANG (University of Macau, Post-doctoral Fellow)
  • Yingqi XU (National University of Singapore, Ph.D. candidate)
  • Yuee CAI (University of Hong Kong, Ph.D. candidate)

Selected Publications

  1. SLX Yang, RE Chen, P Hua, Y Wu, MW Chen*. Integrating Autophagy Inhibition and ROS Clearance in Biohybrid Nanoparticles for Low-Temperature Cancer Photothermal Therapy. Nano Today, 2025, 63: 102737. (IF: 10.9)
  2. JY Zou, FL Xing, QX Zi, HW Du, MW Chen*, W Shu*. Asymmetric Alkyl-alkyl Coupling between Electron-deficient and Unactivated Alkenes to Access α-chiral Phosphines by Ni Catalysis. Science Advances. 2025, 11(24): eadv6571. (IF: 12.5)
  3. EZ Li†, LW Wen†, CY Yin, N Wang, SLX Yang, WZ Feng, MW Chen*. Copper ionophore-autophagy interference nanoregulators for tumor self-defense reprograming to amplify cuproptotic stress and antitumor immunity. Journal of Controlled Release. 2025, 388:114262. (IF: 11.5)
  4. LY Liu†, CY Yin†, X Xiong, ZZ Yang, L Chang, DY Tang, MW Chen*, B Liu*. Self-assembled tannic acid-prodigiosin nanoparticles for synergistic MRSA-infected wound healing and flap repair. Chemical Engineering Journal. 2026, 528, 172140. (IF: 13.2)
  5. RE Chen†, LW Wen†*, F Guo, JW He, KH Wong, MW Chen*. Glutathione-scavenging natural-derived ferroptotic nano-amplifiers strengthen tumor therapy through aggravating iron overload and lipid peroxidation. Journal of Controlled Release, 2025, 379: 866-878. (IF: 11.5)
  6. YY Yin†, KH Wong†, LW Wen, MW Chen*. Active Iron-Drug Nanocomplexes Improve Photodynamic and Photothermal Cancer Therapy by Mitigating Tumor Hypoxia and Counteracting Tumor Heat Resistance. Advanced Healthcare Materials, 2025, 14(9): e2404485. (IF: 9.6)
  7. KH Wong, YX Wang, XW Wang, YY Yin, K Feng, MW Chen*. Unsaturated Fatty acid-doped Liposomes Deliver Piperine to Deactivate Defensive Mechanism for Ferroptosis in Cancer Therapy. Journal of Controlled Release. 2025, 382: 113656. (IF: 11.5)
  8. SLX Yang†, Y Wu†, WZ Zhong, RE Chen, ML Wang, MW Chen*. GSH/pH dual activatable crosslinked and fluorinated PEI for cancer gene therapy through endogenous iron De-Hijacking and in situ ROS amplification. Advanced Materials, 2024, 36(2): e2304098. (IF: 26.8)
  9. FM Chen†, FX Ruan†, XC Xie, JN Lu, W Sun, D Shao*, MW Chen*. Gold Nanocluster: A Photoelectric Converter for X-Ray-Activated Chemotherapy. Advanced Materials, 2024, 36(36): e2402966. (IF: 26.8)
  10. P Hua, RF Liang, SLX Yang, YB Tu, MW Chen*. Microneedle-assisted dual delivery of PUMA gene and celastrol for synergistic therapy of rheumatoid arthritis through restoring synovial homeostasis. Bioactive Materials, 2024, 36: 83-95. (IF: 20.3)
  11. RF Liang†, YB Tu†, P Hua, YZ Huang, MW Chen*. ROS-responsive micelles co-loaded dexamethasone and pristimerin to restore the homeostasis of the inflammatory microenvironment for rheumatoid arthritis therapy. Chinese Chemical Letters, 2025, 36(6): 110335. (IF: 8.9)
  12. MY Zhao, HJ Zhuang, BH Li, MW Chen*, XY Chen*. In Situ Transformable Nanoplatforms with Supramolecular Cross-Linking Triggered Complementary Function for Enhanced Cancer Photodynamic Therapy. Advanced Materials, 2023, 35(20): 2209944. (IF: 26.8)
  13. H Wang, F Lin, Y Wu, W Guo, XS Chen, CS Xiao, MW Chen*. Carrier-Free Nanodrug Based on Co-Assembly of Methylprednisolone Dimer and Rutin for Combined Treatment of Spinal Cord Injury. ACS Nano, 2023, 17(13): 12176-12187. (IF: 16.1)
  14. P Hua†, RF Liang†, YB Tu, YY Yin, MK Law, MW Chen*. Reactive oxygen species and nitric oxide scavenging nanoparticles alleviating rheumatoid arthritis through adjusting the seeds and growing soils. Acta Pharmaceutica Sinica B, 2023, 13(12): 5016-5029. (IF: 14.6)
  15. P Hua†, D Jiang†, ZP Guo†, HY Tian, XS Chen, MW Chen*. Amplified cancer immunotherapy of PD-L1 blockade by sequential tumor microenvironment reshaping and DC maturation. Chemical Engineering Journal, 2023, 453: 139795. (IF: 13.2)
  16. MY Zhao, HJ Zhuang, HX Zhang, BH Li, J Ming, XY Chen*, MW Chen*. A LRET Nanoplatform Consisting of Lanthanide and Amorphous Manganese Oxide for NIR-II Luminescence Lifetime Imaging of Tumor Redox Status. Angewandte Chemie-International Edition, 2022, 61(47), e202209592 (IF: 17)
  17. GJ Song, D Jiang, JC Wu, XZ Sun, MY Deng, L Wang, CX Hao, JY Shi, HT Liu, YQ Tian*, MW Chen*. An ultrasensitive fluorescent breath ammonia sensor for noninvasive diagnosis of chronic kidney disease and helicobacter pylori Chemical Engineering Journal, 2022, 440: 135979 (IF: 13.2)
  18. X Wang, P Hua, CW He, MW Chen*. Non-apoptotic cell death-based cancer therapy: molecular mechanism, pharmacological modulators, and nanomedicine. Acta Pharmaceutica Sinica B, 2022, 12(9), 3567-3593 (IF: 14.6)
  19. SLX Yang†, KH Wong†, P Hua†, CW He, H Yu, D Shao, Z Shi, MW Chen*. ROS-responsive fluorinated polyethyleneimine vector to co-deliver shMTHFD2 and shGPX4 plasmids induces ferroptosis and apoptosis for cancer therapy. Acta Biomaterialia, 2022, 140: 492-505. (IF: 9.6)
  20. WZ Zhong, KH Wong, FJ Xu, NN Zhao, MW Chen*. NIR-responsive polydopamine-based calcium carbonate hybrid nanoparticles deliver artesunate for cancer chemo-photothermal therapy. Acta Biomaterialia, 2022, 145: 135-145 (IF: 9.6)
  21. ZJ Yang, DL Tao, WZ Zhong, Z Liu, LZ Feng*, MW Chen*. Perfluorocarbon loaded fluorinated covalent organic polymers with effective sonosensitization and tumor hypoxia relief enable synergistic sonodynamic-immunotherapy. Biomaterials, 2022, 280:121250. (IF: 12.9)
  22. ZP Guo, YY Hu, MY Zhao, K Hao, P He, HY Tian, XS Chen, MW Chen*. Prodrug-Based Versatile Nanomedicine with Simultaneous Physical and Physiological Tumor Penetration for Enhanced Cancer Chemo-Immunotherapy. Nano Letters, 2021, 21(9): 3721-3730. (IF: 9.1)
  23. ZA Wang†, X Wang†, JB Wan, FJ Xu, NN Zhao, MW Chen*. Optical Imaging in the Second Near Infrared Window for Vascular Bioimaging. Small, 2021, 17(43): 2103780. (IF: 12.1)
  24. CJ Wang, C Liang, Y Hao, ZL Dong, YJ Zhu, QG Li, Z Liu, LZ Feng*, MW Chen*. Photodynamic creation of artificial tumor microenvironments to collectively facilitate hypoxia-activated chemotherapy delivered by coagulation-targeting liposomes. Chemical Engineering Journal, 2021, 414: 128731. (IF: 13.1)
  25. QG Li, ZL Dong, MW Chen*, LZ Feng*. Phenolic molecules constructed nanomedicine for innovative cancer treatment. Coordination Chemistry Reviews, 2021, 439: 213912. (IF: 23.5)
  26. Y Yang, WJ Zhu, L Cheng, R Cai, X Yi, JX He, XS Pan, L Yang, K Yang, Z Liu, WH Tan*, MW Chen*. Tumor microenvironment (TME)-activatable circular aptamer-PEG as an effective hierarchical-targeting molecular medicine for photodynamic therapy. Biomaterials, 2020, 246: 119971. (IF: 12.9)
  27. MW Chen*, XZ Zhou, RE Chen, JL Wang, R D. Ye, YT Wang, CB Wu, R I. Mahato. Nano-carriers for Delivery and Targeting of Active Ingredients of Chinese Medicine for Hepatocellular Carcinoma Therapy. Materials Today, 2019, 25: 66-87. (IF: 22)
  28. TT Pan, C Yang, JY Shi, CX Hao, Y Qiao, JZ Li, MY Deng, YQ Tian*, MW Chen*. Dual pH and Oxygen Luminescent Nanoprobes Based on Graft Polymers for Extracellular Metabolism Monitoring and Intracellular Imaging. Sensors and Actuators B: Chemical, 2019, 291: 306-318. (IF: 7.7)
  29. Y Yang, WJ Zhu, LZ Feng, Y Chao, X Yi, ZL Dong, K Yang, WH Tan, Z Liu*, MW Chen*. G-Quadruplex-Based Nanoscale Coordination Polymers to Modulate Tumor Hypoxia and Achieve Nuclear-Targeted Drug Delivery for Enhanced Photodynamic Therapy. Nano letters, 2018, 18 (11): 6867-6875. (IF: 9.1)
  30. JM Zhang†, JJ Li†, Z Shi, Y Yang, X Xie, SMY Lee*, YT Wang, KW Leong, MW Chen*. pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities. Acta Biomaterialia, 2017, 58: 349-364. (IF: 9.6)
  31. Y Yang, WJ Zhu, ZL Dong, Y Chao, L Xu*, MW Chen*, Z Liu*. 1D Coordination Polymer Nanofibers for Low-Temperature Photothermal Therapy. Advanced Materials, 2017, 29(40): 1703588. (IF: 26.8)
  32. LZ Feng, DL Tao, ZL Dong, Q Chen, Y Chao, Z Liu*, MW Chen*. Near-infrared light activation of quenched liposomal Ce6 for synergistic cancer phototherapy with effective skin protection. Biomaterials, 2017, 127: 13-24. (IF: 12.8)

Book Chapters

  1. 《常見惡性腫瘤：中醫藥基礎與臨床轉化》第三章 原發性肝癌，上海交通大學出版社，2020
  2. The chapter of “Novel nanoparticulate drug delivery systems for active ingredients of traditional Chinese medicine in cancer therapy” in the book ” Molecular Medicines for Cancer: Concepts and Applications of Nanotechnology (First Edition)”, Taylor& Francis-CRC Press Publisher, 2018
  3. 《藥物制劑工程（第三版）》第一章 緒論，化學工業出版社，2018
  4. The chapter of “Preparation, self-assembly, and application of amphiphilic cellulose-based graft copolymers” in the book “Cellulose-Based Graft Copolymers: Structure and Chemistry”, Taylor& Francis-CRC Press Publisher, 2017
  5. The chapter of “Novel formulations and drug delivery systems for phytotherapies” in the book “Phytotherapies: Efficacy, Safety and Regulation”, Wiley, USA, 2015
  6. 《中藥抗腫瘤現代研究技術與進展》第一篇 第四章，人民衛生出版社，2012

1. 一種鴉膽子素D分子印跡聚合物功能化磁性納米顆粒的製備方法及應用。專利號：ZL202311212625.X

2. 一種mRNA納米疫苗及其製備方法和應用。申請號：CN202310981007.5

3. 活性氧活性氮響應的納米複合膠束及其製備方法和納米載藥膠束。申請號：CN202310635961.9

4. 一種過表達SLC31A1和FDX1的藥物及其在治療腎透明細胞癌中的應用。申請號：CN202310473885.6

5. 一種微針、微針貼片及其製備方法。專利號：ZL202111541028.2

6. 一種用于檢測呼吸氨的熒光傳感器及其制備方法和應用。專利號：ZL202110254482.3

7. 一種載EBV-LMP2 mRNA的核-殼納米粒的製備方法及應用。專利號：ZL202011239305.X

8. 酸性當歸多糖ASP3、酸性當歸多糖-阿黴素共聚物納米粒以及兩者的制備方法和應用。專利號：ZL201810900357.3

9. 基于聚氨基酸的藥物體系及其制備方法與用途。專利號：ZL201810723852.1

10. 一種婦女用溫敏凝膠型納米銀泡沫氣霧劑及其制備方法。專利號：ZL200910037397.0

11. 一種煙豆水提取物及其用途。專利號：ZL201710386666.9

12. 煙豆或其提取物在制備治療和/或預防關節炎的藥物中的用途。專利號：ZL201710386672.4

  1. XY Sun, MW Chen*. Dual-pathway STING nanoagoinst amplifies DNA sensing and Golgi trafficking to reprogram immunosuppressive microenvironment for hepatocellular carcinoma therapy. 9th Symposium on Biomedical Sciences for Students, Postdoctoral Fellows and Research Assistants, Macau, China, 19 March, 2025, Merit Award.
  1. YY Yin, KH Wong, MW Chen*. Active iron-based nanocomplex to co-deliver hypericin and apigenin for combined photodynamic and photothermal cancer therapy. 10th Macau Symposium on Biomedical Sciences, Macau, China, 13-15 June, 2024, Best Poster Award.
  1. YB Tu, LH Tan, CW He*, MW Chen*. Dolichosin A alleviates synovial inflammation and inhibits osteoclast differentiation through directly targeting kinase Syk. Exploration International Symposium on Biology, Chemistry, and Medicine, Zhengzhou, China, 21-24 September, 2023, Best Poster Award.
  1. LW Wen. Exploration International Symposium on Biology, Chemistry, and Medicine, Zhengzhou, China, 21-24 September, 2023, Outstanding Editorial Board Member Award.
  1. RF Liang, P Hua, MW Chen*. Dually Reactive Oxygen Species and Reactive Nitrogen Species Scavenging Nanomicelles Deliver JAK-SKAT Inhibitor for Effective Rheumatoid Arthritis Treatment. The 7th National Undergraduate Biomedical Engineering Innovation Design Competition, Hang Zhou, 18-20 August, 2022, Third prize.
  1. P Hua, MW Chen*. Natural Product Based All-active Smart Microneedle Patch for Skin-whitening and Anti-aging. The 17th “Challenge Cup” National Undergraduate Extracurricular Academic Science and Technology Contest, Chengdu, 26-28 March, 2022, Second prize.
  1. GJ Song, D Jiang, YQ Tian*, MW Chen*. A Mitochondria-Targeting NIR Fluorescent potassium ion Sensor: Real-time Investigating Mitochondrial K+ Regulation of Apoptosis in Situ. The 9th China Pharmaceutical Biotechnology Forum, Shenzhen, 25-27 October, 2019, Third prize.
  1. TT Pan, YQ Tian, MW Chen*. Fluorescence Oxygen Biosensors for Cellular Oxygen Monitoring and Imaging-guided Chemotherapy. 2018 Postgraduate Symposium on Chinese Medicinal Sciences, Macao, China, 28-30 October, 2018, Excellence Award.
  1. XZ Zhou, J Li, MW Chen*. Cationic polypeptide-based micelles for camptothecin delivery in lung cancer therapy. 2018 National undergraduate biomedical engineering innovation design competition, Shenzhen, 26-28 August, 2018, First Price.
  1. D Jiang, WZ Zhong, MW Chen*. Co-delivery of camptothecin and siBcl-2 via functional micelles for breast cancer therapy. 2018 National undergraduate biomedical engineering innovation design competition, Shenzhen, 26-28 August, 2018, Third Price.
  1. XZ Zhou, MW Chen*. Lysine-based Cationic Polypeptide Micelles for Enhanced Antitumor Efficacy of Dimeric Camptothecin. 2018 AAPS SYSU-NUS 13th PharmSci@Asia Symposium, Guangzhou, 14-16 June, 2018, Second-Class-Best Podium Presentation Award.
  1. XZ Zhou, MW Chen*. Lysine based cationic polypeptide micelles for dimeric campatothecin delivery in cancer therapy. The 3rd ICMS Academic Seminar for Postgraduate Students, Macau, 19 December, 2017, Third Prize.
  1. MZ Xu, ZP Guo, XZ Zhou, MW Chen*. Dimeric camptothecin-loaded RGD-modified targeted cationic polypeptide-based micelles with high drug loading capacity and redox-responsive drug release capability. The International Symposium for Graduate Students on Pharmaceutical Sciences 2017 & the 3rd Annual AAPS-SYSU Student Chapter Research Symposium, Guangzhou, 7-9 September, 2017, Oral Presentation Second Prize Award.
  1. YQ Xu, MW Chen*. Targeting Nanocarriers for Cancer Therapy: from Cells to Organelles. The 2nd ICMS Postgraduate Student Academic Forum, Macau, 9 December 2016, Excellent Prize.
  1. GJ Song, YX Tian*, MW Chen*. A Ratiometric Fluorescence Phobe for Sensing Mitochondria Bisulfite. The 2nd ICMS Postgraduate Student Academic Forum, Macau, 9 December 2016, Nominee Prize.
  1. Y Yang. Liu’s lab Annual Research Meeting. Soochow, 12 August 2016, Annual Creative Research Award.
  1. LZ Feng, Z Liu*, MW Chen*. Cisplatin-Prodrug-Constructed Liposomes as a Versatile Theranostic Nanoplatform for Bimodal Imaging Guided Combination Cancer Therapy. The 30th Academic Annual Conference of Chinese Chemical Society, Dalian, 1-4 July 2016, Excellent Poster Award.
  1. XB Fang, MW Chen*. Stimuli-responsive Nanoparticle Drug Delivery Systems Based on Poloxamer 188. The 1st ICMS Postgraduate Student Academic Forum, Macau, 11 December 2015, First Prize.
  1. JM Zhang, YT Wang*, MW Chen*. pH-sensitive polymer nanoparticles for co-delivery of doxorubicin and curcumin in treating cancer via enhanced pro-apoptotic and anti-angiogenic activities. IGPS2015&AAPS-SYSU Symposium, Guangzhou, 21-23 August 2015, Oral Presentation Third Prize & Excellent Poster Award.
  1. YQ Xu, MW Chen*. Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated nanoparticles for overcoming multidrug resistance in cancer cells. IGPS2015&AAPS-SYSU Symposium, Guangzhou, 21-23 August 2015, Excellent Poster Award.
  1. SP Wang. The world of Chinese medicine, Chinese medicine of the world. Beijing, 20 August 2014, 9th China Youth Science and Technology Innovation Award. (under Prof Yitao Wang’s and Prof Meiwan Chen’s supervision)
  1. JM Zhang, J Hu, G Liang*, YT Wang, MW Chen*. iRGD decorated lipid-polymer hybrid nanoparticles for targeted co-delivery of doxorubicin and sorafenib to enhance anti-hepatocellular carcinoma efficacy. 2014 Chinese Pharmaceutical Conference. Changsha, 19-21 September 2014, Postgraduate Forum (Third Class Prize).
  1. SP Wang, Y Yang, JM Zhang, YT Wang*, MW Chen*. Gambogic Acid loaded pH-sensitive Mixed Micelles for Overcoming Breast Cancer Resistance. 2014 Chinese Pharmaceutical Conference. Changsha, 19-21 September 2014, Excellent Poster Award (Second Class Prize).
  1. YQ Xu, SP Wang, YT Wang, MW Chen*. Preparation, Characterization, and In Vitro Evaluation of Curcumin-Niosome. 2014 Chinese Pharmaceutical Conference. Changsha, 19-21 September 2014, Excellent Poster Award (Third Class Prize).
  1. YE Cai, XB Fang, JM Zhang, YY Zhu, YT Wang, MW Chen*. Synthesis, Characterization and Anticancer Activity of Pluronic F68-Curcumin Conjugate Micelles. 2014 Chinese Pharmaceutical Conference. Changsha, 19-21 September 2014, Excellent Poster Award (Third Class Prize).

  • Specialty Committee of TCM Pharmaceutical of World Federation of Chinese Medicine Societies (WFCMS), Executive Council Member & Vice Secretary General of the 3rd Board
  • Chinese Drug Preparations Branch of China Association of Chinese Medicine, Committee Member
  • Nano Biotechnology Association, China Medicinal Biotechnology, Committee member
  • Specialty Committee for Integrated Chinese and Western Medicine of Guangdong Province, Executive Committee Member of 6th executive committee
  • Macau Sun Yat-sen Association of Medical Sciences, Executive Member of Director Board
  • Macau Physiological Society, Secretary General & Deputy Managing Director
  • Precision Medicine Association of Macau, Committee Member